Trypanosomatid Parasites Causing Neglected Diseases
Journal:
Current Medicinal Chemistry
Volume:
17
Page:
1594-1617
Author(s):
K. Nussbaum, J. Honek, C. M. C.v.C. Cadmus and T. Efferth
Targeted Hydrolysis of Beta-Amyloid with Engineered Antibody Fragments
Journal:
Current Alzheimer Research
Volume:
7
Page:
214-222
Author(s):
S. Kasturirangan and M. Sierks
Genomic and Molecular Characterization of Alzheimer Disease
Journal:
Current Psychiatry Reviews
Volume:
6
Page:
104-113
Author(s):
Tih-Shih Lee, Sze-Ming Chua, Philip Ly and Weihong Song
Editorial [Hot topic: Inflammation, Immunity, and Alzheimers Disease (Guest Editor: Terrence Town)]
Journal:
CNS & Neurological Disorders - Drug Targets
Volume:
9
Page:
129-131
Author(s):
Terrence Town
Impact of the CD40-CD40L Dyad in Alzheimers Disease
Journal:
CNS & Neurological Disorders - Drug Targets
Volume:
9
Page:
149-155
Author(s):
Brian Giunta, Kavon Rezai-Zadeh and Jun Tan
Amyloid-β Immunotherapy for Alzheimers Disease
Journal:
CNS & Neurological Disorders - Drug Targets
Volume:
9
Page:
197-206
Author(s):
H.J. Fu, B. Liu, J.L. Frost and C.A. Lemere
Abeta DNA Vaccination for Alzheimers Disease: Focus on Disease Prevention
Journal:
CNS & Neurological Disorders - Drug Targets
Volume:
9
Page:
207-216
Author(s):
David H. Cribbs
Update on the Pharmacological Treatment of Alzheimers Disease
Journal:
Current Neuropharmacology
Volume:
8
Page:
69-80
Author(s):
Fadi Massoud and Serge Gauthier
How to Manage the Infectious Risk under Anti-TNF in Inflammatory Bowel Disease
Journal:
Current Drug Targets
Volume:
11
Page:
198-218
Author(s):
Emma L. Culver and Simon P.L. Travis
From Alpha to Omega with Aβ: Targeting the Multiple Molecular Appearances of the Pathogenic Peptide in Alzheimers Disease
Journal:
Current Medicinal Chemistry
Volume:
17
Page:
198-212
Author(s):
L. De Kimpe and W. Scheper